This NDC is on FDA's drug shortage list (posted Apr 2, 2020)
Product Information
MIDAZOLAM HCL 50 MG/10 ML VIAL is a generic product labeled by Heritage Pharmaceuticals Inc., priced at $0.3817 per ML under NDC 23155060142. Its NADAC has been published 94 times since Jun 19, 2024.
FDA first approved this application on Jan 25, 2012. Its Orange Book therapeutic-equivalence code is AP.
Strength
5 mg/mL
Manufacturer
Heritage Pharmaceuticals Inc.NDC
23155060142
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
INTRAMUSCULAR; INTRAVENOUS
Effective Date
9/23/2026
Active Ingredients
MIDAZOLAM HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA090850FDA Approved
1/25/2012
TE Code
AP
On Market Since
11/7/2016
Pharmacological Classes
Price Statistics
The NADAC for MIDAZOLAM HCL 50 MG/10 ML VIAL has been published 94 times since Jun 19, 2024, and over the history we have for it it has risen 5.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3817 per ML |
|---|---|
| All-time high | $0.4500 (Feb 11, 2026) |
| All-time low | $0.3487 (Sep 18, 2024) |
| 52-week high | $0.4500 |
| 52-week low | $0.3817 |
| Median price | $0.4500 |
| Average price | $0.4175 |
| Largest weekly change | -15.2% (Aug 19, 2026) |
| Weeks tracked | 94 |
| Tracking since | Jun 19, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Midazolam hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Heritage Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Midazolam hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Benzodiazepine class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MIDAZOLAM HCL 50 MG/10 ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for MIDAZOLAM HCL 50 MG/10 ML VIAL, manufactured by Heritage Pharmaceuticals Inc., is $0.3817 per ML (NDC 23155060142), effective Sep 30, 2026.
How has the price of MIDAZOLAM HCL 50 MG/10 ML VIAL changed over time?
Over the history we have for it, the NADAC for MIDAZOLAM HCL 50 MG/10 ML VIAL has risen 5.2%. It has been tracked across 94 weekly CMS publications since Jun 19, 2024.
What are the highest and lowest recorded NADAC prices for MIDAZOLAM HCL 50 MG/10 ML VIAL?
Since Jun 19, 2024, the NADAC for MIDAZOLAM HCL 50 MG/10 ML VIAL has ranged from a low of $0.3487 (Sep 18, 2024) to a high of $0.4500 (Feb 11, 2026), with a median of $0.4500 per ML.
Are there cheaper alternatives to MIDAZOLAM HCL 50 MG/10 ML VIAL?
No other NADAC-published product currently shares the active ingredient and strength of MIDAZOLAM HCL 50 MG/10 ML VIAL in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures MIDAZOLAM HCL 50 MG/10 ML VIAL?
MIDAZOLAM HCL 50 MG/10 ML VIAL (NDC 23155060142) is labeled by Heritage Pharmaceuticals Inc., and CMS classifies it as a generic product.
Is MIDAZOLAM HCL 50 MG/10 ML VIAL in shortage?
Yes — NDC 23155060142 is currently listed in FDA's drug shortage database (posted Apr 2, 2020).